How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

267,329 results for

Risk Management

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

81. An agent based architecture for high-risk neonate management at neonatal intensive care unit Full Text available with Trip Pro

An agent based architecture for high-risk neonate management at neonatal intensive care unit In recent years, the use of new tools and technologies has decreased the neonatal mortality rate. Despite the positive effect of using these technologies, the decisions are complex and uncertain in critical conditions when the neonate is preterm or has a low birth weight or malformations. There is a need to automate the high-risk neonate management process by creating real-time and more precise decision (...) support tools.To create a collaborative and real-time environment to manage neonates with critical conditions at the NICU (Neonatal Intensive Care Unit) and to overcome high-risk neonate management weaknesses by applying a multi agent based analysis and design methodology as a new solution for NICU management.This study was a basic research for medical informatics method development that was carried out in 2017. The requirement analysis was done by reviewing articles on NICU Decision Support Systems

2018 Electronic physician

82. Acupressure in Management of Postoperative Nausea and Vomiting in High-Risk Ambulatory Surgical Patients. (Abstract)

Acupressure in Management of Postoperative Nausea and Vomiting in High-Risk Ambulatory Surgical Patients. The purpose of this randomized blinded placebo-controlled research study was to investigate the effect of acupressure over 24 hours postoperatively for ambulatory surgical patients who are identified as high risk for PONV.A randomized blinded placebo-controlled study design was implemented.Study enrollment criteria included four of five risk factors as defined in 2006 by American Society (...) patients finished the study's three phases and nine were admitted postoperatively.Acupressure is an effective minimal risk and low-cost adjunctive therapy for prevention and treatment in ambulatory surgical patients at high risk for PONV. Further studies using other acupressure points should be conducted.Copyright © 2016 American Society of PeriAnesthesia Nurses. Published by Elsevier Inc. All rights reserved.

2018 Journal of perianesthesia nursing : official journal of the American Society of PeriAnesthesia Nurses Controlled trial quality: uncertain

83. Prevena incision management system for closed surgical incisions

Prevena incision management system for closed surgical incisions Pre Prev vena incision management system for closed ena incision management system for closed surgical incisions surgical incisions Medtech innovation briefing Published: 28 February 2019 www.nice.org.uk/guidance/mib173 pathways Summary Summary The technology technology described in this briefing is Prevena. It is a single-use technology for the management of closed surgical incisions that may be at increased risk of infection (...) . The inno innovativ vative aspects e aspects are that Prevena has a multilayer, customisable design, LED display and vacuum-assisted closure connector intended to provide continuous negative pressure to any closed surgical incision. The intended place in ther place in therap apy y would be as an alternative to standard care for managing closed surgical incisions in people at risk of developing surgical site complications. Negative pressure wound therapy is not standard care in the NHS. The main points

2019 National Institute for Health and Clinical Excellence - Advice

84. Prince Edward Island guidelines for the management and control of COVID-19

contact with others. COVID-19 March 4, 2020 • prompt identification • appropriate risk assessment • management and placement of probable and confirmed cases • investigation and follow up of close contacts Early Recognition and Source Control To facilitate early recognition and source control: • triage for identification and appropriate placement (source control) of patients • masks, tissues and alcohol-based hand rubs (ABHR) should be available at entrances • signage should be posted to instruct (...) Guidelines Infection Prevention and Control for Novel Coronavirus (COVID-19): Interim Guidance for Acute Healthcare Settings Routine Practices and Additional Precautions for Preventing the Transmission of Infection in Healthcare Settings Interim guidance: Public health management of cases and contacts associated with novel coronavirus disease 2019 (COVID-19) Public Health Guidance for Schools (K-12) and Childcare Programs (COVID-19) 11 Aerosol-generating medical procedures (AGMPs) are medical procedures

2020 CPG Infobase

85. CVD risk assessment and management

modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease [ ], the Public Health England (PHE) NHS Health Check: best practice guidance [ ], the European Society of Cardiology (ESC) 2016 European guidelines on cardiovascular disease prevention in clinical practice [ ], and a handbook commissioned by the UK National Screening Committee The Handbook for Vascular Risk Assessment, Risk Reduction and Risk Management (...) correction to hyperlinks to the cardiovascular risk charts and calculators provided by the British Hypertension Society. April to June 2006 — reviewed. Validated in September 2006 and issued in October 2006. This guidance has been rewritten following a full literature review and to take account of JBS 2, the second Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. The guidance title has changed from Coronary heart disease — identification and management

2019 NICE Clinical Knowledge Summaries

86. Renal replacement therapy and conservative management

Renal replacement therapy and conservative management Renal replacement ther Renal replacement therap apy and y and conservativ conservative management e management NICE guideline Published: 3 October 2018 nice.org.uk/guidance/ng107 © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Y Y our responsibility our responsibility The recommendations in this guideline represent the view of NICE, arrived at after careful (...) considered for a transplant if risk factors for poor outcomes have been identified; these may include: lack of social support neurocognitive issues non-adherence (medicines, diet, hospital appointments) poor understanding of process and complexities of treatment poorly controlled mental health conditions or severe mental illness substance misuse or dependence. T o find out why the committee made the recommendations on preparing for renal replacement therapy or conservative management – how to assess

2018 National Institute for Health and Clinical Excellence - Clinical Guidelines

87. Chronic heart failure in adults: diagnosis and management

Chronic heart failure in adults: diagnosis and management Chronic heart failure in adults: diagnosis Chronic heart failure in adults: diagnosis and management and management NICE guideline Published: 12 September 2018 nice.org.uk/guidance/ng106 © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Y Y our responsibility our responsibility The recommendations in this guideline represent the view of NICE, arrived at after (...) heart failure 27 4 The impact of advanced kidney disease on the natriuretic peptide threshold for diagnosing heart failure 27 5 Risk tools for predicting non-sudden death in heart failure 28 Update information 29 Chronic heart failure in adults: diagnosis and management (NG106) © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 3 of 37September 2018 29 Recommendations that have been changed 29 Chronic heart failure

2018 National Institute for Health and Clinical Excellence - Clinical Guidelines

88. Pancreatic cancer in adults: diagnosis and management

Pancreatic cancer in adults: diagnosis and management P Pancreatic cancer in adults: diagnosis and ancreatic cancer in adults: diagnosis and management management NICE guideline Published: 7 February 2018 nice.org.uk/guidance/ng85 © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Y Y our responsibility our responsibility The recommendations in this guideline represent the view of NICE, arrived at after careful (...) be: available on an ongoing basis relevant to the stage of the person's condition tailored to the person's needs. 1.4.3 For more guidance on providing information and support, see the NICE guideline on patient experience in adult NHS services. 1.5 Pain management 1.5.1 Consider EUS-guided or image-guided percutaneous neurolytic coeliac plexus block to manage pain for people with pancreatic cancer who: have uncontrolled pancreatic pain or or are experiencing unacceptable opioid adverse effects

2018 National Institute for Health and Clinical Excellence - Clinical Guidelines

89. Oesophago-gastric cancer: assessment and management in adults

Oesophago-gastric cancer: assessment and management in adults Oesophago-gastric cancer: assessment Oesophago-gastric cancer: assessment and management in adults and management in adults NICE guideline Published: 24 January 2018 nice.org.uk/guidance/ng83 © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Y Y our responsibility our responsibility The recommendations in this guideline represent the view of NICE, arrived (...) management. 1.3.7 Only consider F-18 FDG PET-CT in people with gastric cancer if metastatic disease is suspected and it will help guide ongoing management. HER2 testing in metastatic oesophago-gastric adenocarcinoma HER2 testing in metastatic oesophago-gastric adenocarcinoma 1.3.8 Offer HER2 testing to people with metastatic oesophago-gastric adenocarcinoma (see the NICE technology appraisal guidance on trastuzumab for HER2-positive metastatic gastric cancer). 1.4 Radical treatment T1N0 oesophageal

2018 National Institute for Health and Clinical Excellence - Clinical Guidelines

90. Attention deficit hyperactivity disorder: diagnosis and management

Attention deficit hyperactivity disorder: diagnosis and management Attention deficit h Attention deficit hyper yperactivity disorder: activity disorder: diagnosis and management diagnosis and management NICE guideline Published: 14 March 2018 nice.org.uk/guidance/ng87 © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Y Y our responsibility our responsibility The recommendations in this guideline represent the view (...) adjustments at school and college) employment issues (for example, impact on career choices and rights to reasonable adjustments in the workplace) social relationship issues the challenges of managing ADHD when a person has coexisting neurodevelopmental or mental health conditions the increased risk of substance misuse and self-medication the possible effect on driving (for example, ADHD symptoms may impair a person's driving and ADHD medication may improve this; people with ADHD must declare

2018 National Institute for Health and Clinical Excellence - Clinical Guidelines

91. Heavy menstrual bleeding: assessment and management

Heavy menstrual bleeding: assessment and management Hea Heavy menstrual bleeding: assessment vy menstrual bleeding: assessment and management and management NICE guideline Published: 14 March 2018 nice.org.uk/guidance/ng88 © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Y Y our responsibility our responsibility The recommendations in this guideline represent the view of NICE, arrived at after careful consideration (...) Investigations for the cause of HMB Before starting in Before starting inv vestigations estigations 1.3.1 Consider starting pharmacological treatment for HMB without investigating the cause if the woman's history and/or examination suggests a low risk of fibroids, uterine cavity abnormality, histological abnormality or adenomyosis. [2018] [2018] 1.3.2 If cancer is suspected, see the NICE guideline on suspected cancer: recognition and referral. [2007] [2007] Heavy menstrual bleeding: assessment and management

2018 National Institute for Health and Clinical Excellence - Clinical Guidelines

92. Rheumatoid arthritis in adults: management

Rheumatoid arthritis in adults: management Rheumatoid arthritis in adults: Rheumatoid arthritis in adults: management management NICE guideline Published: 11 July 2018 nice.org.uk/guidance/ng100 © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Y Y our responsibility our responsibility The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available (...) with rheumatoid arthritis have the right treatment to slow the progression of their condition and control their symptoms. People should also have rapid access to specialist care if their condition suddenly worsens. NICE has also produced technology appraisal guidance on drug treatment for rheumatoid arthritis. Who is it for? Healthcare professionals Commissioners and providers People with rheumatoid arthritis and their families and carers Rheumatoid arthritis in adults: management (NG100) © NICE 2019. All

2018 National Institute for Health and Clinical Excellence - Clinical Guidelines

93. Dementia: assessment, management and support for people living with dementia and their carers

treatment protocol that balances pain management and potential adverse events. 1.8.5 Repeat pain assessments for people living with dementia: who seem to be in pain who show signs of behavioural changes that may be caused by pain after any pain management intervention. Falls Falls 1.8.6 For guidance on managing the risk of falling for people living with dementia (in community and inpatient settings), see the NICE guideline on falls in older people. When using this guideline: take account (...) Dementia: assessment, management and support for people living with dementia and their carers Dementia: assessment, management and Dementia: assessment, management and support for people living with dementia support for people living with dementia and their carers and their carers NICE guideline Published: 20 June 2018 nice.org.uk/guidance/ng97 © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Y Y our responsibility

2018 National Institute for Health and Clinical Excellence - Clinical Guidelines

94. Chronic obstructive pulmonary disease in over 16s: diagnosis and management

Chronic obstructive pulmonary disease in over 16s: diagnosis and management Chronic obstructiv Chronic obstructive pulmonary disease in e pulmonary disease in o ov ver 16s: diagnosis and management er 16s: diagnosis and management NICE guideline Published: 5 December 2018 nice.org.uk/guidance/ng115 © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Y Y our responsibility our responsibility The recommendations (...) 53 Oral prophylactic antibiotic therapy 54 Long-term oxygen therapy 55 Ambulatory and short-burst oxygen therapy 56 Managing pulmonary hypertension and cor pulmonale 57 Lung volume reduction procedures, bullectomy and lung transplantation 58 Risk factors for COPD exacerbations 59 Self-management, education and telehealth monitoring 60 Context 62 Finding more information and resources 63 Update information 64 Chronic obstructive pulmonary disease in over 16s: diagnosis and management (NG115) ©

2018 National Institute for Health and Clinical Excellence - Clinical Guidelines

95. Managing Menopause Chapter 1 Assessment and Risk Management of Menopausal Women Full Text available with Trip Pro

Managing Menopause Chapter 1 Assessment and Risk Management of Menopausal Women Managing Menopause Chapter 1 Assessment and Risk Management of Menopausal Women - Journal of Obstetrics and Gynaecology Canada Email/Username: Password: Remember me Search Terms Search within Search Volume 36, Issue 9, Supplement 2, Pages S6–S15 Managing Menopause Chapter 1 Assessment and Risk Management of Menopausal Women DOI: To view the full text, please login as a subscribed user or . Click to view the full (...) As outlined in the following chapters of this update to the Canadian Consensus Conference on Menopause 3 and the Canadian Consensus Conference on Osteoporosis, 4 many of the risk factors for the conditions prevalent among older women are modifiable through changes in lifestyle. To access this article, please choose from the options below Log In Register Purchase access to this article Claim Access If you are a current subscriber with Society Membership or an Account Number, . Subscribe to this title

2014 Society of Obstetricians and Gynaecologists of Canada

96. Adolescents' Engagement with Crisis Hotline Risk-management Services: A Report from the Emergency Department Screen for Teen Suicide Risk (ED-STARS) Study. (Abstract)

Adolescents' Engagement with Crisis Hotline Risk-management Services: A Report from the Emergency Department Screen for Teen Suicide Risk (ED-STARS) Study. This study examines the feasibility of a risk-management protocol for adolescent research participants at risk for suicide that relies on engagement with telephone crisis counselors. The study also examines whether engagement is moderated by adolescent demographics and clinical characteristics.Participants were 234 adolescents (83% female (...) ; 63% White) ages 12-18 (M = 15.3 years) drawn from the national study, Emergency Department Screen for Teens at Risk for Suicide (ED-STARS) Study One sample of adolescents randomized for 3-month telephone follow-up (n = 2,850). This study's sample was comprised of adolescents who completed the follow-up (69% retention), met study risk criteria, and were transferred to a crisis hotline for risk management. Engagement with a counselor was assessed by successful call connection, call duration

2019 Suicide & life-threatening behavior Controlled trial quality: uncertain

97. Optimal management of HIV- positive adults at risk for kidney disease in Nigeria (Renal Risk Reduction "R3" Trial): protocol and study design. Full Text available with Trip Pro

Optimal management of HIV- positive adults at risk for kidney disease in Nigeria (Renal Risk Reduction "R3" Trial): protocol and study design. Individuals with two copies of the apolipoprotein-1 (APOL1) gene risk variants are at high risk (HR) for non-diabetic kidney disease. The presence of these risk variants is highest in West Africa, specifically in Nigeria. However, there is limited availability of dialysis and kidney transplantation in Nigeria, and most individuals will die soon after (...) combination antiretroviral therapy (ART) reduces the risk of kidney complications among non-diabetic Nigerian adults.We will screen 2600 HIV-positive adults who have received ART to (1) determine the prevalence of APOL1 risk variants and assess whether APOL1 HR status correlates with prevalent albuminuria, estimated glomerular filtration rate (eGFR), and/or prevalent CKD; (2) assess, via a randomized, placebo-controlled trial (RCT) in a subset of these participants with microalbuminura (n = 280) whether

2019 Trials Controlled trial quality: uncertain

98. Addition of a 161-SNP polygenic risk score to family history-based risk prediction: impact on clinical management in non-<i>BRCA1/2</i> breast cancer families. Full Text available with Trip Pro

Addition of a 161-SNP polygenic risk score to family history-based risk prediction: impact on clinical management in non-BRCA1/2 breast cancer families. The currently known breast cancer-associated single nucleotide polymorphisms (SNPs) are presently not used to guide clinical management. We explored whether a genetic test that incorporates a SNP-based polygenic risk score (PRS) is clinically meaningful in non-BRCA1/2 high-risk breast cancer families.101 non-BRCA1/2 high-risk breast (...) Excellence and the Netherlands (Netherlands Comprehensive Cancer Organisation), respectively.Our results support the application of the PRS in risk prediction and clinical management of women from genetically unexplained breast cancer families.© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

2019 Journal of Medical Genetics

99. Cardiovascular Risk and Risk Factor Management in Type 2 Diabetes: A Population-Based Cohort Study Assessing Sex Disparities. Full Text available with Trip Pro

Cardiovascular Risk and Risk Factor Management in Type 2 Diabetes: A Population-Based Cohort Study Assessing Sex Disparities. With recent changes in UK clinical practice for diabetes care, contemporary estimates of sex disparities in cardiovascular risk and risk factor management are needed.In this retrospective cohort study, using the Clinical Practice Research Datalink linked to hospital and death records for people in England, we identified 79,985 patients with incident T2DM between 2006 (...) -2013 matched to 386,547 patients without diabetes. Sex-stratified Cox models were used to assess cardiovascular risk.Compared to women without T2DM, women with T2DM had a higher cardiovascular event risk (adjusted HR 1.20 [95% CI 1.12-1.28]) with similar corresponding data in men (HR 1.12 [1.06-1.19]) leading to a non-significant higher relative risk in women (risk ratio 1.07 [0.98-1.17]). However, some important sex differences in the management of risk factors were observed. Compared to men

2019 Circulation

100. Reducing the Risk of Preterm Birth by Ambulatory Risk Factor Management. Full Text available with Trip Pro

Reducing the Risk of Preterm Birth by Ambulatory Risk Factor Management. The preterm birth rate in Germany has remained unchanged at 8-9% since 2009. Preterm birth is the most common cause of neonatal morbidity and mortality. In the absence of a causal treatment, it is important to lower the risk of preterm birth by preventive measures in prenatal outpatient care.This review is based on pertinent publications from the years 2000-2019 that were retrieved by a selective search in PubMed.The (...) clinical risk factors for preterm birth-known mainly from retrospective cohort studies-include previous preterm birth (adjusted odds ratio [aOR]: 3.6), multiple pregnancy (relative risk [RR]: 7.7), nicotine consumption (aOR: 1.7), and a short uterine cervix, i.e., <25 mm in the second trimester (aOR: 6.9). In women with a short cervix, vaginally administered progesterone significantly lowers the preterm birth rate (22.5% vs. 14.1% for birth before 33 weeks of gestation, RR: 0.62; 95% confidence

2019 Deutsches Arzteblatt international

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>